

Publisher: Karger
E-ISSN: 1423-0224|45|3|134-138
ISSN: 0302-282x
Source: Neuropsychobiology, Vol.45, Iss.3, 2002-04, pp. : 134-138
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Plasma Catecholamine Levels after Fluoxetine Treatment in Depressive Patients
Neuropsychobiology, Vol. 51, Iss. 2, 2005-03 ,pp. :






Neuropsychobiology, Vol. 66, Iss. 3, 2012-08 ,pp. :


Plasma Omentin Levels in Drug-Free Patients with Schizophrenia
Neuropsychobiology, Vol. 69, Iss. 3, 2014-05 ,pp. :